Conditions: Follicular Thyroid Carcinoma

Thyroid nodule versus thyroid cancer

A thyroid nodule is a general term for a growth or lump that forms within the thyroid gland. As about 5% of all nodules are cancerous, almost all thyroid nodules prove not to be cancerous after evaluation.

What is follicular thyroid carcinoma?

Follicular thyroid carcinoma (FTC) is the second most common type of thyroid cancer. The thyroid is a small, butterfly-shaped gland at the front of your neck that produces hormones to help regulate your metabolism, heart rate, and body temperature. FTC develops from the follicular cells that make these hormones. It accounts for about 4–15% of all thyroid cancers.

How is it different from papillary thyroid cancer?

While both are considered "well-differentiated" thyroid cancers with generally good outcomes, FTC behaves differently in important ways:

• FTC tends to spread through the bloodstream rather than through the lymph system, so it is more likely to spread to distant organs (such as bones and lungs) than to nearby lymph nodes in the neck.

• FTC cannot be diagnosed by a needle biopsy alone — surgery is needed to examine the outer shell (capsule) of the tumor under a microscope to confirm the diagnosis.

• FTC is classified as minimally invasive, encapsulated angioinvasive, or widely invasive, based on how far the tumor has grown through its capsule and into nearby blood vessels.

• Tumors that were once labeled "Hürthle cell carcinoma" are now generally classified as a distinct, oncocytic type of thyroid cancer rather than as a subtype of FTC.

What causes it?

In most cases, there is no single clear cause. Known risk factors include:

• Iodine deficiency (more common in certain parts of the world)

• Exposure to radiation, especially during childhood

• Family history of thyroid cancer

• Certain inherited genetic conditions (such as PTEN hamartoma tumor syndrome/Cowden syndrome, DICER1 syndrome, or Carney complex)

Most people diagnosed with FTC have none of these risk factors.

What are the symptoms?

Most people with FTC have no symptoms. The cancer is often found during a routine physical exam or on an imaging test done for another reason. When symptoms do occur, they may include:

• A painless lump or nodule in the neck

• A feeling of fullness or pressure in the neck

• Difficulty swallowing

• Hoarseness or voice changes (less common, usually with more advanced disease)

In some cases, the first sign of FTC may be a symptom from a distant spread (metastasis), such as bone pain.

How is it diagnosed?

• Ultrasound of the thyroid and neck is the main imaging test.

• Fine-needle aspiration (FNA) biopsy can suggest a "follicular neoplasm," but it cannot tell the difference between a benign (non-cancerous) follicular adenoma and a follicular carcinoma.

• Surgery (lobectomy) is usually needed to remove the thyroid nodule so a pathologist can examine the entire capsule under a microscope. The diagnosis of FTC requires finding evidence of the tumor invading through its capsule or into blood vessels.

• Molecular testing on the biopsy sample may help estimate the likelihood of cancer and guide decisions about surgery.

• Most follicular neoplasms found on biopsy — roughly 80–90% — turn out to be benign adenomas rather than cancer once the tissue is examined after surgery.

WHAT IS THE OUTLOOK?

The outlook for FTC depends on the type:

• Minimally invasive FTC: The 10-year survival rate is approximately 98%. This type has an excellent prognosis.

• Widely invasive FTC: The prognosis is less favorable, with a 10-year survival rate of approximately 66–80%. Distant metastases (spread to bones or lungs) are the most important factor affecting survival.

• Early-stage FTC overall: A large population study found that cancer-specific death remained below 1.5% at 10 years for patients with stage I–II disease.

Even when FTC has spread, many patients respond well to radioactive iodine treatment and can live for many years.

What follow-up is needed after treatment?

Regular follow-up is very important. Your doctor will monitor you with:

• Physical examinations

• Blood tests (thyroglobulin, thyroglobulin antibodies, and TSH levels)

• Neck ultrasounds

• Additional imaging if needed

For patients at low risk who remain cancer-free for 10–15 years, ongoing monitoring for thyroid cancer may no longer be necessary.